Literature DB >> 24426580

Use of glutaraldehyde-preserved bovine pericardium patch in vascular repair of portal vein in a patient with pancreatic cancer.

Alberto Mitsuo Leon-Takahashi1, Antonio Gomez-Pedraza2, Antonio Cruz-Rodriguez2, Juan Manuel Ruiz-Molina2, Alejandro Padilla-Rosciano2, Angel Herrera-Gomez2.   

Abstract

Advanced-stage gastrointestinal tumors are aggressive and frequently invade blood vessels. Advances in endovascular surgery can repair blood vessels that may be infiltrated by a tumor. Currently there are many materials to do this, as the use of prostheses or implants and patches. In Mexico, the bovine pericardium preserved with glutaraldehyde has been used to treat incisional, inguinal, and diaphragmatic hernias and repair vascular defects with good results, low cost, and no allergic reaction from the patient. We report the case of a 47-year-old man, with a history of smoking and alcoholism, diagnosed with pancreatic adenocarcinoma. The tumor, with the use of endoscopic ultrasound, showed direct contact with the portal vein without invading the confluence of the mesenteric vein. During exploratory laparotomy, a tumor attached to the head of the pancreas of 4 cm × 4 cm was found, with tumor invasion of 1 cm × 2 cm on the outer sidewall of the portal vein. We performed pylorus-preserving pancreatoduodenectomy and tumor resection of the portal vein wall with placement of glutaraldehyde-preserved bovine pericardium patch to repair it. The intraoperative and immediate postoperative period arose without complications. The patient was discharged with good result and is currently under surveillance. We report this case to show a successful result using glutaraldehyde-preserved bovine pericardium to close vascular defects after resection of the tumor secondary to vascular invasion.

Entities:  

Keywords:  Glutaraldehyde-preserved bovine pericardium patch; Pancreatic cancer; Portal vein injury

Year:  2012        PMID: 24426580      PMCID: PMC3693362          DOI: 10.1007/s12262-012-0655-9

Source DB:  PubMed          Journal:  Indian J Surg        ISSN: 0973-9793            Impact factor:   0.656


  6 in total

1.  Surgical treatment of pancreatic tumors invading the spleno-mesenteric-portal vessels. An Italian Multicenter Survey.

Authors:  A M Taschieri; M Elli; M Rovati; G M Sampietro; M Cristaldi; P Danelli; M Pisacreta
Journal:  Hepatogastroenterology       Date:  1999 Jan-Feb

2.  Lyophilized glutaraldehyde-preserved bovine pericardium for experimental atrial septal defect closure.

Authors:  J Alfredo Santibáñez-Salgado; J Raúl Olmos-Zúñiga; María Pérez-López; Carlos Aboitiz-Rivera; Miguel Gaxiola-Gaxiola; Rogelio Jasso-Victoria; Avelina Sotres-Vega; Matilde Baltazares-Lipp; Diana Pérez-Covarrubias; Jaime Villalba-Caloca
Journal:  Eur Cell Mater       Date:  2010-04-21       Impact factor: 3.942

3.  Significance of the depth of portal vein wall invasion after curative resection for pancreatic adenocarcinoma.

Authors:  Saburo Fukuda; Elie Oussoultzoglou; Philippe Bachellier; Edoardo Rosso; Hiroshi Nakano; Maxime Audet; Daniel Jaeck
Journal:  Arch Surg       Date:  2007-02

4.  Application of pericardial graft in the surgical management of Peyronie's disease.

Authors:  W J Hellstrom; S Reddy
Journal:  J Urol       Date:  2000-05       Impact factor: 7.450

5.  Heart valve replacement with the Ionescu-Shiley pericardial xenograft.

Authors:  M I Ionescu; A P Tandon; D A Mary; A Abid
Journal:  J Thorac Cardiovasc Surg       Date:  1977-01       Impact factor: 5.209

6.  Glutaraldehyde-preserved bovine pericardium for the repair of diaphragmatic defects due to extensive metastatic liver resection.

Authors:  Ilka de Fatima Boin; João Luiz Joaquim; Luiz Sergio Leonardi
Journal:  Hepatogastroenterology       Date:  2003 May-Jun
  6 in total
  1 in total

1.  Patency rates of portal vein/superior mesenteric vein reconstruction after pancreatectomy for pancreatic cancer.

Authors:  A N Krepline; K K Christians; K Duelge; A Mahmoud; P Ritch; B George; B A Erickson; W D Foley; E J Quebbeman; K K Turaga; F M Johnston; T C Gamblin; D B Evans; S Tsai
Journal:  J Gastrointest Surg       Date:  2014-09-17       Impact factor: 3.452

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.